Why the study?
Does Anti-α4 Integrin Antibody reduce monocyte/macrophage traffic to the heart and decrease cardiac pathology in a SIV infection model of AIDS?
Does Anti-α4 Integrin Antibody reduce monocyte/macrophage traffic to the heart and decrease cardiac pathology in a SIV infection model of AIDS?
Targeting macrophage activation and traffic with anti-α4 integrin antibody may alleviate HIV- and SIV-associated myocarditis and fibrosis.
Answers are grounded in this paper and cite their sources.
May reduce HIV myocarditis in models; hypothesis-generating from animal data only.
These data demonstrate a role for macrophages in the development of cardiac inflammation and fibrosis, and suggest that blocking monocyte/macrophage traffic to the heart can alleviate HIV- and SIV-associated myocarditis and fibrosis. They underscore the importance of targeting macrophage activation and traffic as an adjunctive therapy in HIV infection.
No takes yet. Share an insight, caveat, or question.
Walker et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: